Literature DB >> 6579964

Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias.

R Hahn, K Oette, H Mondorf, K Finke, H G Sieberth.   

Abstract

A group of 252 chronic hemodialysis patients was examined for various risk factors. Special emphasis was placed upon the comparison of patients who had marked cardiovascular alterations with the remainder of the group. The seriousness of the risk factors was determine by hypertension and hyperlipoproteinemia, 78% of the patients received antihypertensive medication or had changes in the fundus of the eye or both. In 74% of the patients there were pathological changes in the plasma lipids or lipoproteins or both. Hypertriglyceridemia (49%) and a HDL cholesterol decrease (61%) were the most striking findings. The average VLDL cholesterol value was significantly higher and the HDL cholesterol significantly lower in the coronary heart disease group than in the remaining group. These results show that hyperlipoproteinemia and a decrease in HDL, together with other risk factors such as hypertension and anemia, play an important role in the accelerated development of atherosclerosis in a hemodialysis group.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6579964     DOI: 10.1016/0021-9150(83)90045-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

1.  Potential role of carnitine in patients with renal insufficiency.

Authors:  C Wanner; W H Hörl
Journal:  Klin Wochenschr       Date:  1986-07-01

2.  Changes of serum lipids and lipoproteins during haemodialysis treatment in dialysed chronic uraemic patients.

Authors:  A László; M Németh; I Joó; E Kiss; Z Havass; P Szenohradszki
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

Review 3.  [Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].

Authors:  C J Olbricht
Journal:  Klin Wochenschr       Date:  1991-08-01

4.  Influence of diabetes on persistent nonhealing ischemic foot ulcer in end-stage renal disease.

Authors:  Hiroshi Yasuhara; Shuji Naka; Hironobu Yanagie; Hirokazu Nagawa
Journal:  World J Surg       Date:  2002-07-22       Impact factor: 3.352

5.  Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure.

Authors:  N M Al-Saady; E W Leatham; S Gupta; J T Kwan; J B Eastwood; C A Seymour
Journal:  Heart       Date:  1999-02       Impact factor: 5.994

6.  Changes and correlations of antioxidant enzymes, lipid peroxidation and serum neutral lipids due to haemodialysis treatment in chronic uraemic patients.

Authors:  B Matkovics; A László; S I Varga; G Gál; T Solymosi
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 7.  Disturbances of lipid metabolism in children with chronic renal failure.

Authors:  U Querfeld
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

8.  The lipid story in chronic kidney disease: a long story with a happy end?

Authors:  Agata Kujawa-Szewieczek; Andrzej Więcek; Grzegorz Piecha
Journal:  Int Urol Nephrol       Date:  2013-10       Impact factor: 2.370

9.  Serum lipid profile constituents as markers of cardiovascular morbidity in patients on chronic hemodialysis.

Authors:  Dimitrios Kirmizis; Evangelia Koutoupa; Apostolos Tsiandoulas; Aphroditi Valtopoulou; Georgios Niavis; Phani Markou; Konstantinos Barboutis
Journal:  Biomark Insights       Date:  2007-02-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.